PEN Penumbra Inc
Price (delayed)
$277.35
Market cap
$10.68B
P/E Ratio
770.42
Dividend/share
N/A
EPS
$0.36
Enterprise value
$10.58B
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses
Highlights
PEN's revenue is up by 13% year-on-year and by 2.6% since the previous quarter
PEN's gross profit is up by 11% year-on-year and by 3.2% since the previous quarter
PEN's equity is up by 4.2% since the previous quarter but it is down by 2.4% year-on-year
The price to earnings (P/E) is 114% higher than the last 4 quarters average of 360.4
The net income has plunged by 85% YoY and by 59% from the previous quarter
Key stats
What are the main financial stats of PEN
Market
Valuations
Earnings
Shares outstanding
38.52M
Market cap
$10.68B
Enterprise value
$10.58B
Price to earnings (P/E)
770.42
Price to book (P/B)
9.25
Price to sales (P/S)
8.97
EV/EBIT
507.04
EV/EBITDA
237.41
EV/Sales
8.86
Revenue
$1.19B
Gross profit
$755M
Operating income
$9.28M
Net income
$14.01M
EBIT
$20.87M
EBITDA
$44.57M
Free cash flow
$147.3M
Per share
Balance sheet
Liquidity
EPS
$0.36
EPS diluted
$0.36
Free cash flow per share
$3.81
Book value per share
$29.99
Revenue per share
$30.92
TBVPS
$35.22
Total assets
$1.53B
Total liabilities
$382.25M
Debt
$223.39M
Equity
$1.15B
Working capital
$792.78M
Debt to equity
0.19
Current ratio
6.01
Quick ratio
3.21
Net debt/EBITDA
-2.27
Margins
Efficiency
Dividend
EBITDA margin
3.7%
Gross margin
63.2%
Net margin
1.2%
Operating margin
0.8%
Return on assets
0.9%
Return on equity
1.2%
Return on invested capital
1.8%
Return on capital employed
1.5%
Return on sales
1.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PEN stock price
How has the Penumbra stock price performed over time
Intraday
-0.16%
1 week
3.27%
1 month
0.46%
1 year
32.91%
YTD
16.79%
QTD
3.72%
Financial performance
How have Penumbra's revenue and profit performed over time
Revenue
$1.19B
Gross profit
$755M
Operating income
$9.28M
Net income
$14.01M
Gross margin
63.2%
Net margin
1.2%
PEN's operating margin has plunged by 88% YoY
Penumbra's operating income has shrunk by 87% YoY
Penumbra's net margin has shrunk by 86% YoY and by 60% QoQ
The net income has plunged by 85% YoY and by 59% from the previous quarter
Growth
What is Penumbra's growth rate over time
Valuation
What is Penumbra stock price valuation
P/E
770.42
P/B
9.25
P/S
8.97
EV/EBIT
507.04
EV/EBITDA
237.41
EV/Sales
8.86
The price to earnings (P/E) is 114% higher than the last 4 quarters average of 360.4
PEN's EPS has shrunk by 85% YoY and by 60% QoQ
The stock's P/B is 32% above its last 4 quarters average of 7.0 but 3.6% below its 5-year quarterly average of 9.6
PEN's equity is up by 4.2% since the previous quarter but it is down by 2.4% year-on-year
PEN's price to sales (P/S) is 28% higher than its last 4 quarters average of 7.0 but 16% lower than its 5-year quarterly average of 10.7
PEN's revenue is up by 13% year-on-year and by 2.6% since the previous quarter
Efficiency
How efficient is Penumbra business performance
The ROE has plunged by 86% YoY and by 60% from the previous quarter
The ROA has plunged by 85% YoY and by 59% from the previous quarter
PEN's ROS has shrunk by 77% YoY but it is up by 31% QoQ
The company's return on invested capital has shrunk by 73% YoY but it rose by 38% QoQ
Dividends
What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PEN.
Financial health
How did Penumbra financials performed over time
Penumbra's quick ratio has increased by 5% QoQ
Penumbra's total assets has increased by 3.7% from the previous quarter
Penumbra's debt is 81% lower than its equity
PEN's debt to equity is down by 10% since the previous quarter and by 5% year-on-year
Penumbra's debt has decreased by 4.7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.